High Tide and NuLeaf Naturals Join U.S. National Compassionate Care Council as Founding Members

High Tide (Nasdaq: HITI) and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals joined the U.S. National Compassionate Care Council as founding members on March 4, 2026.

Rhea-AI Summary

High Tide (Nasdaq: HITI) and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals joined the U.S. National Compassionate Care Council as founding members on March 4, 2026.

The companies said this role aims to help modernize medical cannabis policy, improve patient access to cannabinoid therapies, and contribute industry expertise amid federal rescheduling and Medicare reimbursement discussions.

Other founding members include Feals, Medterra, Tilray, Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria.

Argus Mar 4 session

-1.20% close to close Open Argus

Details

News Market Reaction – HITI

In the Mar 4 session, HITI declined 1.20%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement underscores High Tide’s effort to align its U.S. hemp-derived CBD subsidiaries wit...

Analysis

This announcement underscores High Tide’s effort to align its U.S. hemp-derived CBD subsidiaries with evolving federal and state cannabis policy. Joining the NCCC as a founding member ties the company to discussions on Medicare reimbursement and healthcare standards for cannabinoid therapies. In context of recent expansion and record financials, a key watchpoint is how participation in this council eventually affects patient access, regulatory clarity, and utilization of brands like NuLeaf Naturals across the U.S. healthcare landscape.

Key Figures

Current share price: $2.50 52-week range: $1.64–$4.0554 Canadian stores: 219 locations +5 more

Current share price

$2.50

Pre-news trading level for HITI

52-week range

$1.64–$4.0554

52-week low and high for HITI

Canadian stores

219 locations

Canna Cabana retail footprint in Canada

Canadian market share

12%

Share across five Canadian provinces

Customer reviews

35,000+ 5-star reviews

Verified NuLeaf Naturals e-commerce reviews

Countries licensed

19 countries

Remexian import licenses for medical cannabis

Volume vs average

1.39x

Today’s volume relative to 20-day average

Market capitalization

$221,356,132

Equity value prior to this news

Historical Context

5 past events · Latest: Mar 03

5 events

1. Mar 03

   Board refresh, advisors

   24h Move

   -0.8%

   New directors and advisors focused on real estate and artificial intelligence.

2. Feb 09

   Store opening

   24h Move

   +3.0%

   New Scarborough Canna Cabana store raises footprint to 219 Canadian locations.

3. Jan 29

   Earnings results

   24h Move

   -8.2%

   Record Q4 revenue and EBITDA plus free cash flow and German expansion.

4. Jan 09

   Earnings date notice

   24h Move

   -0.8%

   Announcement of dates for Q4 and full-year 2025 results and webcast.

5. Dec 23

   Year milestone recap

   24h Move

   +0.0%

   Recap of 2025 growth, including revenue run-rate and German entry.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

hemp-derived cbd, cannabinoid therapies, medicare reimbursement, cannabis policy, +2 more

6 terms

hemp-derived cbd medical

"its leading U.S. hemp-derived CBD subsidiary, NuLeaf Naturals"

Hemp-derived CBD is a non-psychoactive compound taken from hemp plants, used in oils, capsules, foods and topical products for potential calming or wellness effects. For investors it matters because products containing hemp-derived CBD sit at the intersection of consumer demand, tight regulation and supply-chain considerations—like betting on a new everyday commodity—so changes in rules, safety data or consumer trends can quickly affect sales and company valuations.

cannabinoid therapies medical

"improving patient access to cannabinoid therapies by modernizing healthcare standards"

Treatments that use cannabinoids — chemical compounds found in the cannabis plant or made in a lab — to prevent, relieve, or manage medical conditions. Think of them as a new class of medicines derived from a familiar plant, where effectiveness, legal status, and safety rules vary by country; investors care because clinical results, approval decisions, and changing regulations can quickly alter market size, company value, and risk exposure.

medicare reimbursement regulatory

"explore Medicare reimbursement for hemp-derived cannabinoid products"

Medicare reimbursement is the payment a government health insurance program makes to hospitals, doctors, drugmakers and device makers for covered treatments, drugs or services. Think of it as the price a very large customer agrees to pay a seller; the level and timing of those payments influence how much revenue a health company can earn, how it prices products, and how quickly new treatments are adopted, so changes in reimbursement often directly affect investor returns and risk.

cannabis policy regulatory

"help contribute to the development of thoughtful U.S. federal and state medical cannabis policy"

Cannabis policy is the set of laws, regulations and company rules that determine how cannabis products are grown, sold, advertised, transported, financed and researched. For investors it matters because these rules shape who can operate, how much it costs to comply, which markets are open or closed, and the legal risk companies face—like a traffic rulebook that controls which roads businesses can use and how fast they can move.

cgmP-certified technical

"Most of NuLeaf's products are produced at its cGMP-certified facility"

cgmp-certified indicates that a company's manufacturing facilities and processes meet current Good Manufacturing Practice standards set by health regulators to ensure products are made consistently, safely and meet quality requirements. For investors, certification lowers the chance of regulatory action, recalls or production stoppages and supports market access and trust—like a restaurant passing a strict health inspection that protects customers and the business.

forward-looking statements regulatory

"CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CALGARY, AB, March 4, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, and its leading U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, today announced they have joined the National Compassionate Care Council (NCCC) as founding members.

"Federal cannabis policy in the United States is entering a meaningful transition," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Through our experience building health-focused brands such as NuLeaf Naturals and FAB CBD, we have developed meaningful expertise in serving consumers seeking cannabinoid-based wellness products within a responsible regulatory framework. We are pleased to join the NCCC so that High Tide and NuLeaf can help contribute to the development of thoughtful U.S. federal and state medical cannabis policy, while supporting efforts aimed at improving patient access to cannabinoid therapies across the United States," added Mr. Grover.

The NCCC is dedicated to improving patient access to cannabinoid therapies by modernizing healthcare standards and advancing evidence-based policy. The Council brings together healthcare-focused organizations across the medicinal cannabis sector that prioritize product quality, research, and patient outcomes.

In addition to High Tide and its subsidiaries NuLeaf Naturals and FAB CBD, founding members include Feals, Medterra CBD LLC, Tilray Inc., Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria.

Recent federal initiatives to reschedule cannabis and explore Medicare reimbursement for hemp-derived cannabinoid products signal a potential shift in U.S. healthcare policy that can have a material impact for High Tide's U.S. based hemp-derived CBD subsidiaries. Through its participation in the NCCC, High Tide aims to contribute industry expertise while supporting broader efforts to expand patient access to safe and effective cannabinoid therapies.

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 219 domestic locations. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.

Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

ABOUT NULEAF NATURALS

Founded in 2014 in Denver, Colorado, NuLeaf Naturals is one of America's leading cannabinoid companies. Since its inception, the company has been committed to creating the world's highest-quality cannabinoid products in their purest and most potent form. Most of NuLeaf's products are produced at its cGMP-certified facility, enabling it to manufacture ground-breaking cannabinoid formulations while exceeding the highest levels of regulatory compliance. Their cannabinoid products are sold direct-to-consumer from their website and are also available at select bricks-and-mortar stores across the U.S. The company is committed to creating safe, consistent, and effective products and has proudly received over 35,000 verified 5-star customer reviews through its e-commerce platform. 

CONTACT INFORMATION

Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: future shifts in U.S. policy, impact on the Corporation's subsidiaries, and outcomes of the coalition. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-and-nuleaf-naturals-join-us-national-compassionate-care-council-as-founding-members-302703951.html

SOURCE High Tide Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does High Tide (HITI) joining the NCCC mean for patient access to cannabinoid therapies?

It signals an intent to support broader patient access to cannabinoid therapies in the U.S. According to the company, participation in the NCCC will let High Tide share industry expertise to help modernize healthcare standards and advance evidence-based policy affecting patient access.

Which organizations joined the National Compassionate Care Council alongside High Tide on March 4, 2026?

Founding members include Feals, Medterra, Tilray, Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria. According to the company, the council unites healthcare-focused cannabinoid organizations prioritizing product quality, research, and patient outcomes.

How might federal rescheduling and Medicare reimbursement developments affect High Tide's U.S. CBD business (HITI)?

These federal initiatives could materially affect High Tide's U.S. hemp-derived CBD subsidiaries' market access and reimbursement. According to the company, such policy shifts may change healthcare and payment pathways for hemp-derived cannabinoid products.

What role will NuLeaf Naturals play as a founding member of the NCCC?

NuLeaf Naturals will contribute expertise on health-focused, hemp-derived cannabinoid products and regulatory compliance. According to the company, NuLeaf brings cGMP manufacturing experience and a focus on product quality and patient outcomes.

Does High Tide describe this NCCC membership as strategic for its U.S. operations (HITI)?

Yes; the company positioned the membership as strategic for shaping U.S. medical cannabis policy and patient access. According to the company, High Tide aims to leverage its wellness-brand experience to influence thoughtful federal and state policy development.